Skip to Content

Tag: John Rademacher


John Rademacher

Specialty Providers

Option Care Health shows ‘resilience’

May 6, 2022Theresa Flaherty, Managing Editor

BANNOCKBURN, Ill. – After a “sluggish” start in the first quarter of 2022, the rest of the year looks to be “productive” for Option Care Health, says CEO John Rademacher.  “As we entered the year, we were in the midst of the COVID resurgence related to the omicron variant,” said Rademacher on a recent earnings call. “This had a very disruptive impact on our referral patterns and local pharmacy operation. Given the resilience of our teams in...

Home Infusion Therapy, John Rademacher, Option Care Health


Read Full Articlered right arrow icon

John Rademacher

Specialty Providers

Option Care Health sees nursing as path to growth

February 25, 2022Theresa Flaherty, Managing Editor

BANNOCKBURN, Ill. – Option Care Health in 2021 invested more than $100 million, including both a recent acquisition and a planned acquisition, as it seeks to build out a “critical” national nursing network, said CEO John Rademacher.  On a Feb. 24 earnings call, the company said it had acquired Salt Lake City, Utah-based Wasatch Infusion, with four infusion centers, for $18 million in December. It also announced that it has entered into an agreement to acquire Sarasota, Fla.-based...

Home Infusion Therapy, John Rademacher, Option Care Health


Read Full Articlered right arrow icon

John Rademacher

Specialty Providers

Option Care Health reports Q4, full year growth

February 23, 2022HME News Staff

BANNOCKBURN, Ill. – Option Care Health reported net revenue of $927.2 million for the fourth quarter of 2021 and gross profit of $212.2 million, increases of just over 15% compared to the fourth quarter of 2020. Net revenue for the full year was about $3.4 billion, an increase of about 13.4% and gross profit was $779.6 million, or 22.7% of revenue, an increase of 14.2% over 2020. Adjusted EBITDA was $289.8 million. The company also announced that it acquired Wasatch Infusion LLC, an infusion...

Home Infusion Therapy, John Rademacher, Option Care Health


Read Full Articlered right arrow icon

John Rademacher

Specialty Providers

WellSky, Option Care Health promote interoperability

January 6, 2022HME News Staff

OVERLAND PARK, Kan. – WellSky Health and Option Care Health will launch CommonWell Health Alliance services in all 50 states in the second quarter of 2022 to help facilitate health information exchange.  Option Care Health will join CommonWell through WellSky I/O, accessible within WellSky’s electronic health record system.  “Option Care Health is a pioneer in the infusion therapy space and WellSky is proud to partner with them to further their interoperability initiatives,”...

John Rademacher, Option Care Health, WellSky


Read Full Articlered right arrow icon

John Rademacher

Specialty Providers

Option Care credits new therapies, infusion suites for growth

November 12, 2021Theresa Flaherty, Managing Editor

BANNOCKBURN, Ill. – Option Care Health recorded its second straight quarter of “high-teens growth” for its chronic therapy portfolio and sees ongoing opportunity in the $100 billion market, says CEO John Rademacher.  “We did have some new therapies that were introduced that we continue to see traction on moving forward,” he said on a recent call to discuss the company’s third quarter earnings. “I think, as we have defined the market, it's $100...

Home Infusion Therapy, John Rademacher, Option Care


Read Full Articlered right arrow icon

Option Care invests for future growth

Specialty Providers

Option Care invests for future growth

November 4, 2021HME News Staff

BANNOCKBURN, Ill. – Option Care Health reported net revenue of $891.9 million and gross profit of $203 million for third quarter of 2021, compared to $781.6 million and $174.2 million, respectively, in the same quarter last year.  Net income was $35.5 million vs. $1.7 million. Adjusted EBITDA was $78 million vs. $59.2 million.  “The third quarter results reflect the dedication of the entire team and our ability to generate profitable growth and significant cash flow,”...

Home Infusion Therapy, John Rademacher, Option Care Health


Read Full Articlered right arrow icon

Option Care hungry for M&A 

Specialty Providers

Option Care hungry for M&A 

May 14, 2021Theresa Flaherty, Managing Editor

BANNOCKBURN, Ill. – With a tuck-in acquisition in the Southeast, a new state-of-the-art facility in Chicago and new therapies added to its chronic care portfolio, Option Care Health is laying the groundwork for sustainable growth, say company officials.  Option Care announced May 6 it had paid $18.5 million for Houston-based BioCureRx, a regional provider of certain chronic care therapies.  “While limited in size, the BioCure transaction signifies...

Home Infusion Therapy, John Rademacher, Option Care Health


Read Full Articlered right arrow icon

Option Care Health reports ‘solid’ results 

Specialty Providers

Option Care Health reports ‘solid’ results 

May 7, 2021HME News Staff

BANNOCKBURN, Ill. – Option Care Health reported revenue of $759.2 million for the first quarter of 2021, an increase of 7.6% compared to $705.4 million for the same period last year.   Gross profit was $165.5 million, or 21.8% of net revenue, and adjusted EBITDA was $52.2 million for the quarter.  “The Option Care Health team delivered solid financial results in the first quarter while continuing to lay the foundation for sustained growth,” said John Rademacher,...

Home Infusion Therapy, John Rademacher, Option Care Health


Read Full Articlered right arrow icon

Option Care sees growth driven by chronic care 

Specialty Providers

Option Care Health sees growth driven by chronic care 

March 26, 2021Theresa Flaherty, Managing Editor

BANNOCKBURN, Ill. – Option Care Health saw double-digit growth in revenues as the company took advantage of its technology platform to respond to the disruption caused by the COVID-19 pandemic, said CEO John Rademacher on a recent earnings call.  Option Care Health reported net revenues of $804.7 million for the fourth quarter of 2020, an increase of 11.6% compared to the same quarter in 2019.  “Our ability to quickly pivot and utilize our technology...

Coronavirus Outbreak, Home Infusion Therapy, John Rademacher, Option Care Health


Read Full Articlered right arrow icon

Also Noted

Option Care Health reports $3B in revenues for 2020 

March 11, 2021HME News Staff

BANNOCKBURN, Ill. – Option Care Health reported net revenues of $804.7 million for the fourth quarter of 2020, an increase of 11.6% compared to the same quarter in 2019. Net revenues for the full year were about $3 billion, an increase of 31.3% compared to the full year 2019. Adjusted EBITDA for the quarter was $67.7 million, and $221.7 million for the full year, up 27.7% and 69.5%, respectively. “I am incredibly proud of the effort and execution by the Option Care Health team in...

Home Infusion, John Rademacher, Option Care Health


Read Full Articlered right arrow icon